Research programme: integrin and cell adhesion molecule modulators - Aviara Pharmaceuticals/Texas Heart Institute
Latest Information Update: 19 Jan 2017
At a glance
- Originator Aviara Pharmaceuticals; Texas Heart Institute
- Class Small molecules
- Mechanism of Action Cell adhesion molecule modulators; Integrin modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Stem cell mobilisation
Most Recent Events
- 16 Jan 2017 Early research in Stem cell mobilisation in USA (unspecified route)